$7.34
0.65[9.72%]
At close: Apr 26
$7.34
0[0.00%]
After Hours: 5:19PM EDT
Pulse Biosciences
(NASDAQ:PLSE)Pulse Biosciences Stock (NASDAQ:PLSE), Analyst Ratings, Price Targets, Predictions
Pulse Biosciences Inc has a consensus price target of $4, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Maxim Group, HC Wainwright & Co., and Stephens & Co. on September 21, 2022, May 13, 2022, and April 1, 2022. With an average price target of $4 between Maxim Group, HC Wainwright & Co., and Stephens & Co., there's an implied -45.50% downside for Pulse Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
HC Wainwright & Co.
Stephens & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Pulse Biosciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/21/2022 | PLSE | Buy Now | Pulse Biosciences | $7.34 | — | Maxim Group | Anthony Vendetti | — | Downgrade | Buy → Hold | Get Alert |
| 05/13/2022 | PLSE | Buy Now | Pulse Biosciences | $7.34 | — | HC Wainwright & Co. | Swayampakula Ramakanth | — | Downgrade | Buy → Neutral | Get Alert |
| 04/01/2022 | PLSE | Buy Now | Pulse Biosciences | $7.34 | 63.49% | Stephens & Co. | Chris Cooley | $14 → $12 | Maintains | Overweight | Get Alert |
| 04/01/2022 | PLSE | Buy Now | Pulse Biosciences | $7.34 | 15.8% | HC Wainwright & Co. | Swayampakula Ramakanth | $20 → $8.5 | Maintains | Buy | Get Alert |
| 02/10/2022 | PLSE | Buy Now | Pulse Biosciences | $7.34 | 172.48% | HC Wainwright & Co. | Swayampakula Ramakanth | $43 → $20 | Maintains | Buy | Get Alert |
| 11/16/2021 | PLSE | Buy Now | Pulse Biosciences | $7.34 | 485.83% | HC Wainwright & Co. | Swayampakula Ramakanth | — | Maintains | Buy | Get Alert |
| 07/27/2021 | PLSE | Buy Now | Pulse Biosciences | $7.34 | 281.47% | Stephens & Co. | Chris Cooley | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Pulse Biosciences (PLSE)?
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on September 21, 2022. The analyst firm set a price target for $0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pulse Biosciences (PLSE)?
The latest analyst rating for Pulse Biosciences (NASDAQ: PLSE) was provided by Maxim Group, and Pulse Biosciences downgraded their hold rating.
When was the last upgrade for Pulse Biosciences (PLSE)?
There is no last upgrade for Pulse Biosciences.
When was the last downgrade for Pulse Biosciences (PLSE)?
The last downgrade for Pulse Biosciences Inc happened on September 21, 2022 when Maxim Group changed their price target from N/A to N/A for Pulse Biosciences Inc.
When is the next analyst rating going to be posted or updated for Pulse Biosciences (PLSE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pulse Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pulse Biosciences was filed on September 21, 2022 so you should expect the next rating to be made available sometime around September 21, 2023.
Is the Analyst Rating Pulse Biosciences (PLSE) correct?
While ratings are subjective and will change, the latest Pulse Biosciences (PLSE) rating was a downgraded with a price target of $0.00 to $0.00. The current price Pulse Biosciences (PLSE) is trading at is $7.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.